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Macrophages secrete a wide range of biologically active mediators in response
to inflammatory stimuli (reviewed in reference 1) . Some of these products, such
as IL-1 and cachectin/TNF, have been well characterized (2, 3), whereas others
remain poorly defined . Early studies suggested that during inflammation, se-
creted products ofactivated macrophages elicit a wide variety of tissue responses
including neutrophil infiltration and activation (see references 4 and 5 for
reviews) . However, identification of the specific monocyte-derived endogenous
mediators responsible for these effects has been difficult and has frequently led
to conflicting results . Furthermore, many of the biological responses seen with
crude or partially purified products of activated macrophages have not been
reproduced with recombinant-derived cytokines, suggesting that some biologi-
cally important peptides have yet to be identified (6, 7) .
During the purification and characterization of cachectin/TNF (8) and an
inhibitor of Friend erythroleukemic cell differentiation (9, 10), a third protein
was observed with interesting physical properties. Evidence is presented here
that this protein, which appears as a doublet of 8,000 daltons on SDS-polya-
crylamide gels, forms multimers of varied molecular masses up to and exceeding
10'daltons as assessed by gel filtration . Partial NH2-terminal amino acid sequence
information reveals no significant homology with any previously described pro-
tein . The monokine is anionic under physiological conditions but is one of two
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major heparin-binding proteins secreted by these cells. This monokine, which
we term "macrophage inflammatory protein" (MIP),' induces neutrophil che-
mokinesis and, to a lesser extent, hydrogen peroxide production in vitro. In
addition, MIP elicits a localized inflammatory response when administered sub-
cutaneously.
Materials and Methods
Materials. Purified, recombinant human cachectin/TNF was obtained from Chiron
Corp., Emeryville, CA. Purified, human rIL-Ia was the generous gift of Dr. P. Lomedico
(Hoffman-La Roche, Inc., Nutley, NJ). All chemicals were of the highest grades available
from commercial suppliers.
Animals.
￿
C3H/HeN mice were obtained from Charles River Breeding Laboratories,
Inc. (Kingston, NY). Mice of the endotoxin-resistant C3H/HeJ strain were obtained from
Jackson Laboratories (Bar Harbor, ME).
Cell Culture.
￿
The mouse macrophage cell line RAW 264.7 and the cachectin/TNF-
sensitive cell line L929 were obtained from American Type Culture Collection (Rockville,
MD) and maintained in RPMI 1640 or DMEM (Gibco, Grand Island, NY), respectively.
Both media were supplemented with 20 mM Hepes and 10% FCS (HyClone Laboratories,
Sterile Systems, Inc., Logan, UT). For the production of stimulated RAW 264.7 super-
natants, cells were grown in 150-mm tissue culture dishes (Falcon Labware, Becton,
Dickinson & Co., Oxnard, CA) in RPMI plus 10% FCS until they reached confluency.
The cells were washed five times in HBSS and the medium was replaced with serum-free
RPMI supplemented with 1 jug/ml of LPS (LPS W, E. coli 0127 :B8, Difco Laboratories,
Inc ., Detroit, MI). The cells were incubated at 37°C for 16-18 h and the supernatants
filtered through 0.22-um filters.
Purification ofMIP.
￿
1-5 liters of supernatant were concentrated 16-40-fold in a DC2
hollow fiber concentration system with a 10,000-dalton cutoff (Amicon Corp., Lexington,
MA) and diafiltrated against 6 liters of 20 mM Tris buffer, pH 8 .0, using the same device.
Octyl glucoside was added to the concentrated, diafiltrated supernatant to a final concen-
tration of 1 % (wt/vol) and the mixture was applied to a Mono Q 10/10 (anion exchange
[Pharmacia Fine Chemicals, Rahway, NJ]) column previously equilibrated with 20 mM
Tris buffer, pH 8 .0, and connected to a fast protein liquid chromatography (FPLC;
Pharmacia Fine Chemicals) apparatus. A linear gradient of 114 ml (total vol) from 0 to 1
M NaCl in the same buffer (and a flow rate of 2 ml/min) was used for elution.
Samples of each fraction were subjected to SDS-PAGE in 10-15% or 10-18% linear
gradient slab gels under reducing conditions. Molecular mass standards (Bethesda Re-
search Laboratories, Bethesda, MD) were run in parallel. Fractions containing MIP eluted
in the same region as cachectin/TNF and were easily recognized as a characteristic doublet
of -8,000 daltons.
Peak MIP-containing fractions (as assessed by SDS-PAGE and silver staining) were
pooled, concentrated, and fractionated on a high-performance gel filtration column
(Superose 12 ; Pharmacia Fine Chemicals) previously equilibrated with 100 mM ammo-
nium acetate. MIP was recovered in the void volume of the column and was >95% pure
as judged by SDS-PAGE and silver staining. MIP purified in this manner contained ^-0.2
ng LPS/ug MIP.
Heparin Chromatography.
￿
Heparin-conjugated Sepharose (Pharmacia Fine Chemicals)
was used to assay the ability of MIP to bind heparin. A C10/20 column (Pharmacia Fine
Chemicals) packed with 8 ml of gel was attached to FPLC and equilibrated with 20 mM
Tris, pH 8 .0 . 2 ml of 12-fold-concentrated and diafiltrated RAW 264 .7 supernatant (as
above) was applied to the column, and a linear gradient of 0-2 M NaCl in the same buffer
was used for elution.
Chromatofocusing.
￿
8 jug of a peak MIP-containing fraction from Mono Q chromatog-
' Abbreviations used in this paper:
￿
FPLC, fast protein liquid chromatography; GBSS, Gey's bal-
anced salt solution; MIP, macrophage inflammatory protein ; PMN, polymorphonuclear leukocyte.572
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raphy was equilibrated in 25 mM bis-Tris plus 10% betaine (wt/vol), pH 7 .1, and applied
to a Mono P column previously equilibrated in the same buffer. Protein was eluted with
a linear gradient of Polybuffer 74 (Pharmacia Fine Chemicals) (1 :10 in double-distilled
water) with 10% betaine, pH 4.0, resulting in a descending pH gradient ranging from 7-
4.
Protein Assay.
￿
Protein content was measured by the Bradford assay (11) using BSA as
a standard (Bio-Rad Laboratories, Richmond, CA).
EndotoxinAssay.
￿
Endotoxin levels were determined using a chromogenic limulus assay
(Whittaker M .A. Bioproducts, Walkersville, MD) according to the instructions of the
manufacturer.
Protein Sequencing.
￿
Purified MIP was sequenced by the Rockefeller University protein-
sequencing facility. The Dayhoff protein sequence bank was searched for homologous
amino acid sequences using the computer program P-fast-D .
In Vivo Inflammatory Activity.
￿
Polymorphonuclear leukocyte (PMN) infiltration was
evaluated using footpad injections, according to Granstein et al. (12). Briefly, female
C3H/HeJ mice (6-12 wks) were lightly anesthesized with phenobarbital (25 mg/kg body
weight, i.p.). Animals were randomized to receive a subcutaneous footpad injection of
0.05 ml containing either 10-'° mol N-FMLP; 10, 100, or 1,000 ng of human rIL-la or
recombinant human cachectin/TNF; or 1, 10, 100, or 1,000 ng of murine MIP (purified
as above) in RPMI 1640 with 0.1 % FCS. RPMI 1640 with 0 .1 % FCS alone served as a
control. In some cases, mice received the test substance in one hindlimb footpad and the
control carrier in the contralateral hindlimb. In other cases, a randomized block design
was used. Mice were sacrificed 4 h after injection and hindlimbs were fixed in 10%
buffered formalin. Hindlimbs were decalcified, embedded in paraffin, and thin sections
of footpads were stained with hematoxylin and eosin.
In Vitro PMNMigration Assays.
￿
Heparinized venous blood was obtained from healthy
volunteers. Leukocytes containing >95% PMNs, as judged by cell sorter analysis, were
isolated by Ficoll-Hypaque density gradient centrifugation and dextran sedimentation
(13). Residual erythrocytes were removed by lysis with hypotonic saline. Cells were
resuspended in Gey's balanced salt solution (GBSS; pH 7 .4) and 2% BSA to a final
concentration of 2.5 x 105 cells/ml.
In vitro chemokinesis was assayed using a modification of the technique described by
Boyden (14). Bottom wells of blind well chambers were filled with 25 Eel ofchemoattractant
(FMLP [10' M], MIP, or buffer) and the top wells filled with 45 Eel of GBSS/BSA
containing 1 .1 x 10' PMNs. The two wells were separated by a cellulose nitrate membrane
with a 3-AM pore size (SM 11302; Sartorius Balances, Westbury, NY). Chambers were
incubated at 37'C in a humidified 5% COz, 95% room air chamber for 45 min.
Membranes were removed and stained according to a previously described protocol (15).
The number of PMNs migrating into the membrane was counted every 10 AM up to 130
EiM using an automated Optomax Imaging system (Optomax, Inc., Hollis, NH). Migration
was quantitated in three randomly selected fields for each membrane with each sample
tested in triplicate. Chemokinesis was defined as the mean distance migrated into the
membrane (expressed as %) compared to GBSS alone (0%) and that of the positive FMLP
control (100%).
Chemokinetic data are expressed as the mean ± SEM of the percent control chemoki-
netic response. A one-way analysis of variance was used to compare the response to MIP
with that of GBSS alone in the bottom well of the Boyden chamber.
Induction ofHydrogen Peroxide Release.
￿
The ability of MIP to elicit the release of Hz02
from adherent human PMNs or monocytes was tested by the method recently described
in detail (16). In brief, PMNs and mononuclear leukocytes in heparinized or citrated
blood were isolated in Neutrophil Isolation Medium (Packard Instrument Co. Inc.,
Downer's Grove, IL), washed, and plated separately at 1 .5 x 10' PMNs or 2 x 105
mononuclear cells per well in flat-bottomed, 6-mm diameter polystyrene tissue culture
wells that had previously been coated with FCS and extensively washed. The assay mixture
contained 2.4 nmol scopoletin, 0.5 ug horseradish peroxidase, 1 mM sodium azide, and
the indicated test agents in a final volume of 0 .13 ml of Krebs-Ringer phosphate bufferFroctíon number
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Results
FIGURE 1 . Fractionation of concentrated, diafiltrated supernatant from RAW 264 .7 on
Mono Q. 2 liters of supernatant were concentrated twenty times and diafiltrated against 6
liters of 20 mM Tris-HCI, pH 8.0 . The concentrated supernatant was applied to Mbno Q and
eluted with a linear gradient of0-1 M NaCl in the same buffer. MIP (*) eluted slightly before
cachectin/TNF (**) at -0.37 M NaCl . The inset shows a 10-15% SDS-PAGE gel to which 50
/,I from the indicated fractions have been applied .
with glucose at 37°C . Loss of fluorescence of scopoletin due to oxidation by H202 was
recorded at 15- or 30-min intervals in a plate-reading fluorometer and converted to nmol
H 202 by microcomputer (17) .
IL-1 and Cachectin/TNF Bioassays .
￿
MIP was assayed for IL-1 activity by its ability to
stimulate C3H/HeJ thymocytes to undergo blastogenesis in the presence of suboptimal
quantities of phytohemagglutinin, as previously described (18) .
Cachectin/TNF activity was assayed by its ability to kill actinomycin D-treated L929
murine fibroblasts (19) . Approximately 50,000 L929 cells were plated in each well of a
96-well plate (Falcon Labware, Becton, Dickinson & Co .) in DME containing 1 ttg/ml
actinomycin D and increasing quantities of MIP . After 14-16 h, the chromogen (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) was added and the cells incubated
for an additional 4 h . Cell viability was assessed by the ability of the cells to reduce the
chromogen during this time period by a modification of the method of Mosmann (20) .
The medium was aspirated and the cells were lysed with 0.04 N hydrochloric acid in
isopropanol . After addition of 1 vol double-distilled water, the extent of chromogen
reduction was assayed by reading the plates at OD 570/690 using an automated ELISA
plate reader, and values were compared to a standard curve obtained with recombinant
human cachectin/TNF . Cachectin/TNF was also assayed by the suppression of lipoprotein
lipase on 3T3-L1 cells as previously described (8) . The ability of MIP to induce cachec-
tin/TNF in primary cultures of macrophages was assessed by eliciting macrophages with
an i.p . injection of 2 ml of sterile thioglycollate broth (Difco Laboratories Inc .) and
collecting the cells 4-6 d later by peritoneal lavage . The cells were washed and resuspended
in serum-free RPMI and plated at 10 6 cells/well in 24-well tissue culture plates . Test
substances (LPS, 0.001-1 wg/ml ; MIP, 1 Kg/ml) were added and the cells incubated at
37°C for 18 h . The cell-free supernatants were collected and assayed for cachectin/TNF
activity by cytotoxicity on L929 cells as described above.
Purification of MIP.
￿
When supernatants of stimulated RAW 264 .7 were
fractionated by Mono Q (anion exchange) chromatography, MIP was apparent
as a distinctive doublet of ^x8,000 daltons on SDS-PAGE after silver staining
(Fig . 1) ; it reproducibly eluted within a fraction or two of cachectin/TNF at574
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--0 .37 M NaCl and appeared to be produced in approximately the same quantities
as judged by silver staining.
Chromatofocusing revealed that Mono Q-purified MIP eluted at a slightly
more acidic pH than cachectin/TNF. This corresponded to a pI of 4.6 (not
shown).
To further purify MIP, advantage was taken of its tendency to aggregate. The
aggregation of MIP was observed to occur during the concentration of the crude
material and before diafiltration or fractionation on Mono Q (data not shown).
When fractionated by gel filtration in PBS, MIP formed multimers of various
molecular masses ranging from ^-20,000 daltons to material eluting in the void
volume (?2 X 106 daltons; data not shown). In 100 mM ammonium acetate this
tendency was exaggerated and the majority of the protein eluted in high
molecular mass fractions (Fig. 2). Under these conditions, MIP of >95% purity,
as judged by SDS-PAGE and silver staining, was obtained. A heparin-binding
protein that cochromatographs on Mono Q and Superose 12 and comigrates on
SDS-PAGE with MIP from RAW 264.7 cells is recovered from supernatants of
cultured thioglycollate-elicited primary C3H/HeN murine macrophages in re-
sponse to LPS treatment in vitro (data not shown).
Partial NHz-terminal amino acid sequence data of purified MIP (Fig. 3) showed
a single major sequence although sequences of two separate batches showed a
consistent minor peak at three positions out of the first 31 residues. The sequence
data revealed no significant homologies with any previously described protein .
Affinity of MIP for Heparin.
￿
During the purification of MIP, an affinity was
noted for heparin (Fig. 4). When 2 ml of 12-fold-concentrated RAW 264 .7
supernatant was applied to the column and eluted with a linear gradient of 0-2
M NaCl, MIP was one of two major proteins detected by SDS-PAGE and silver
staining, eluting at ^-0.7 M NaCl.
Determination of Biological Activities.
￿
At concentrations as high as 20 ug/ml,
MIP did not stimulate blastogenesis of C3H/HeJ thymocyt,es; human rIL-la, on
the other hand, was active in this assay at concentrations as low as 10 pg/ml (data
not shown). Similarly, MIP did not kill L929 cells in the presence of actinomycin
D even at concentrations of 1 kg/mlwhereas recombinant human cachectin/TNF
was able to induce killing at concentrations as low as 15 pg/ml (data not shown).
Further, MIP did not induce down-regulation of lipoprotein lipase in 3T3-L1
cells (data not shown). At 1 Ag/ml, MIP did not induce cachectin/TNF produc-
tion by primary thioglycollate-elicited mouse macrophages in the presence of 10
,ug/ml polymyxin B (data not shown) .
Although free of the above-mentioned IL-1- and cachectin/TNF-like activities,
MIP induced a localized inflammatory response at 4 h when injected subcuta-
neously into the footpads of C3H/HeJ mice. Maximal inflammation occurred
when 100 ng of MIP were administered and was characterized primarily by a
PMN infiltration (Fig. 5B). The control response to an injection of carrier is
shown in Fig. 5A . The degree of neutrophil infiltration seen with MIP was not
as marked as that seen when 10-' ° mol of FMLP were administered (Fig. 5D).
However, the degree of neutrophil infiltration was comparable to that observed
with 10 ng of recombinant cachectin/TNF. Human rIL-1 elicited no inflamma-
tory responses at 4 h when administered at these doses (data not shown). MIPWOLPE ET AL .
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(1)
￿
(lo)
Ala-Pro-Tyr-Gly-Ala-Asp-Thr Pro-Thr-Ala-X-X-Phe-Ser-Tyr-Ser-Arg-Lys-Ile-
(Met)
￿
(Pro ;
￿
(Thr)
Effluent
￿
Fraction number
0 4 8
￿
16 24 32 40 48
2 .0
FIGURE 3 . Amino acid sequence
for the first 31 positions of MIP. Res-
idues in parentheses indicate posi-
tions at which minor peaks were ob-
tained in two different sequence runs
on different batches of material .
z
FIGURE 4 .
￿
Binding of MIP to heparin . 2 ml of 12-fold-concentrated and diafiltrated RAW
264.7 supernatant were applied to a heparin-Sepharose column and eluted with a linear
gradient of 0-2M NaCl . Two major peaks were observed ; MIP (*) eluted in the second peak,
corresponding to 0.6-0.75 M NaCl . The insert shows a 10-18% SDS-PAGE gel to which 50
gI from the indicated fractions have been applied .
induced chemokinesis in human neutrophils in vitro . Data presented in Fig . 6
represent the mean percent of the control migratory response of five experi-
ments. Values are presented as the percent increase in neutrophil migration
relative to the negative GBSS and positive FMLP control (10-a M) . At concen-
trations ?100 ng/ml, MIP elicited a significant increase in neutrophil migration
(p< 0.01 by analysis of variance) . Inclusion of polymyxin B (10 Ag/ml) had no
effect on MIP-induced chemokinesis . Further, LPS at concentrations of 10-
1,000 ng/ml was not active in this assay (data not shown) .
Recombinant cachectin/TNF, but not rIL-lß, triggers a delayedbut significant
respiratory burst in human PMN, provided the cells are adherent to a surface
coated with serum or extracellular matrix proteins (16) . Similarly, MIP at >1
ug/ml triggered adherent PMN to release H202 in four experiments, one of
which is illustrated in Fig . 7 . Compared to cachectin/TNF tested at the same
time, the response to MIP was more delayed (60-min lag vs . 15-min lag for
cachectin/TNF), and the maximal sustained rate was smaller (1 .2 nmol/min per
106 PMN vs . 3.0 for cachectin/TNF and 2.1 for PMA) . However, the duration
of the response was greater (2.5 h compared to 1 h for cachectin/TNF) and the
total amount ofH202 released was similar . Because MIP binds heparin, experi-
ments were also performed with PMN isolated from citrated rather than hepa-WOLPE ET AL . 577
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FIGURE 6. Induction of neutrophil
chemokinesis by MIP. Data represent
the mean percent of the control migra-
tory response of five experiments. Val-
uesarepresentedas thepercent increase
in neutrophil migration relative to the
negative GBSS and the positive FMLP
control (10-8 M). (*) Concentrations of
MIP showing significant increases in the
percent chemokinetic response over
GBSS alone (p < 0.01 by analysis of
variance).
FIGURE 7. Stimulation of H202 release by
MIP. Human PMN incubated in serum-coated
microtest plate wells were treated at time 0
with PMA (100 ng/ml; *); recombinant cach-
ectin/TNF (10 ng/ml; A), MIP (1,000 ng/ml;
0); or an equivalent volume of buffer alone
(control; A). H202 release was monitored over
thenext 4.5 h (2 h for cachectin/TNF). Values
aremeans±SEMfortriplicates in I of4similar
experiments.
rinized blood and gave similar results. Neither MIP (not shown) nor cachec-
tin/TNF (16) triggered H202 release from monocytes.
Discussion
In the present communication we describe the isolation of a novel monokine
that we term MIP. This monokine bears no significant sequence homology to
any previously described protein yet shares some of the overlapping properties
typical of inflammatory mediators such as cachectin/TNF and IL-1 .
MIP was isolated on the basis of its interesting physical properties. Although
MIP migrates as a doublet of 8,000 daltons on SDS-PAGE, it readily forms
high molecular mass aggregates in excess of 2 X 106 daltons as judged by gel
filtration. It is not clear at the present time why there is a doublet observed on
SDS-PAGE. Partial amino acid sequence data show one major sequence with
minor peaks at three positions. It is possible that these twobands representallelic
forms of the same protein, alternative splicing of the same gene product orWOLPE ET AL.
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partial proteolytic digestion. The binding of MIP to heparin under conditions
where the protein is anionic suggests a specific interaction. This is further
emphasized by the observation that MIP is one of two major macrophage-
secreted proteins that bind to heparin at high salt concentrations. It is possible
that MIP may play a role in the coordination of the inflammatory activities of
macrophages, mast cells, and neutrophils. MIP may also interact with basement
membrane proteoglycans during inflammation. We are currently investigating
the nature of the other major protein that binds to heparin under these condi-
tions.
The findings presented here are consistent with the suggestion that both
cachectin/TNF and MIP are capable of inducing an inflammatory response.
Cachectin/TNF has previously been shown to induce neutrophil chemokinesis
(21, 22) as well as activation (16, 23-25). In the present study, MIP was shown
also to be capable ofinducing neutrophil chemokinesis. In addition, at the doses
used here, cachectin/TNF and MIP each elicited similar degrees ofinflammation
in vivo. Although others have shown that rIL-1a can induce an inflammatory
reaction in vivo (12), no such effect was found here; it is possible that the human
rIL-la used here is less active in this regard than the murine IL-la used by
Granstein et al. (12).
MIP consistently induced only low and variable levels of hydrogen peroxide
production by human PMNs. Whether this low level of response is due to the
aggregation of the protein during purification or reflects its actual biological
activity is not clear at the present time. It is also possible that the small and
delayed response is due to an undetected contaminant. It is not known for any
of the bioactivities reported here whether the protein deaggregates under the
conditions used or what is the active form. It is therefore difficult to assign a
specific activity on a molar basis for these activities.
It is unlikely that these effects ofMIPadministration are due to cachectin/TNF
contamination as there was no cachectin/TNF bioactivity detected in the L929
assay at the doses used. Further, MIP did not induce primary thioglycollate-
elicited macrophages to produce cachectin/TNF. Endotoxin contamination was
ruled out as an explanation as the chemokinesic effect was not affected by the
presence of polymyxin B; and LPS itself, at concentrations greater than were
present in the assay, had no effect. The inflammation induced by MIP was
observed in the endotoxin-resistant C3H/HeJ mouse strain using preparations
with low levels ofendotoxin contamination (0.2 ng LPS/jug MIP).
It is ofinterest that several monokines secreted by macrophages share overlap-
ping properties. Cachectin/TNF and IL-I have a number of bioactivities in
common (1); it now appears that a third monokine, MIP, is capable of inducing
some of the inflammatory reactions elicited by cachectin/TNF. It will be of
interest to see how the production of these various monokines is controlled in
vivo as well as whether they synergize in their various bioactivities. Recently,
Yoshimura et al. (7) provided evidence for a chemotactic factor from human
peripheral blood mononuclear cells of a molecular mass of ^-10,000 daltons by
gel filtration and a pI of 8.0-8.5. As their basic protein has not yet been fully
characterized, its relationship to the acidic one described here is not known.
Additional biological roles for MIP require further investigation. Preliminary580
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data indicate that several cell types bear receptors for this monokine. Thepresent
results suggest that this novel heparin-binding protein is produced in sizable
amounts after endotoxin stimulation and may play a role in the cascade of host
responses to endotoxemia and inflammation. Investigations are under way to
further define the biological activities of this monokine as well as its interactions
with other macrophage products.
Summary
We report the identification and purification ofa new inflammatory monokine
synthesized by the macrophage tumor cell line RAW 264.7 in response to
endotoxin. This monokine, which we term "macrophage inflammatory protein"
(MIP), is a doublet with an apparent molecular mass of 8,000 daltons on SDS-
PAGE but forms aggregates of >2 x 106 daltons as assessed by gel filtration.
Partial NHl-terminal amino acid sequence data reveal no significant homology
with any previously described protein. Although the monokine is anionic under
physiological conditions, it is one of two major macrophage-secreted proteins
that bind to heparin at high salt concentrations.
At 100 ng/ml or greater, MIP is chemokinetic for human polymorphonuclear
cells and triggers hydrogen peroxide production. Subcutaneous injection of 10
ng or greater of MIP into footpads of C3H/Hej mice elicits an inflammatory
response, characterized by neutrophil infiltration. These findings suggest that
MIP is an endogenous mediator that may play a role in the host responses that
occur during endotoxemia and other inflammatory events.
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